Global /China /Healthcare /Drug Manufacturers - General /600222

Henan Taloph Pharmaceutical Stock Co.,Ltd

600222

• SSE: 600222 • Delayed

6.80CNY -3.3%

1.01 USD

As of 17 June 2026, Henan Taloph Pharmaceutical Stock Co.,Ltd has a market cap of $575.22M USD, ranking #14245 globally and #4395 in China. It ranks #1271 in the Healthcare sector, and #473 in the Drug Manufacturers - General industry.

Global Rank

14245

Country Rank

4395

Sector Rank

1271

Industry Rank

473

Key Stats

Market Cap

$575.22MUSD

3.89B CNY

Enterprise Value

$649.98MUSD

4.39B CNY

Revenue (TTM)

$260.12MUSD

1.76B CNY

EBITDA (TTM)

$27.56MUSD

186.25M CNY

Net Income (TTM)

$8.88MUSD

60.0M CNY

EBITDA Margin

11%

Profit Margin

3.4%

PE Ratio

64.8

PS Ratio

2.2

PB Ratio

2.3

EV/EBITDA

22.1

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jingliang Li open_in_new

Employees

2,214

Founded

1993

Website

taloph.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3.3%	-2.3%	-3%	1.9%	7.3%	4.9%	34%	16%	15%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	600222 河南太龙药业股份有限公司 Class A ISIN: CNE0000010L8 Shares Out.: Shares Outstanding: 552.924M¹ Shares Float: 423.743M² TV: TradingView: SSE: 600222 SA: Stock Analysis: SHA: 600222 YF: Yahoo Finance: 600222.SS GF: Google Finance: SHA: 600222 BA: Barron's: 600222 MS: Morningstar: XSHG: 600222	6.80 CNY	TV: TradingView: SSE: 600222 SA: Stock Analysis: SHA: 600222 YF: Yahoo Finance: 600222.SS GF: Google Finance: SHA: 600222 BA: Barron's: 600222 MS: Morningstar: XSHG: 600222

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Henan Taloph Pharmaceutical Stock Co.,Ltd

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, pediatric Qingrezhike oral liquid, Huoxiangzhengqi mixture, Danshen and Wuzi Yanzong oral liquid, Shengmaiyin, pediatric compound chicken gizzard chewable tablets, Huperzine A tablets, compound Yimu oral liquid. The company serves hospitals, primary medical institutions, and retail terminals. Henan Taloph Pharmaceutical Stock Co.,Ltd was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. The company was founded in 1993 and is based in Zhengzhou, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$54.0B 364.89B CNY 9K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.78B 336.36B CNY 9K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.53B 223.48B HKD 5K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.81B 147.32B HKD 3K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.56B 111.89B CNY 3K%	-	China
Akeso, Inc. SHEK: 9926	$16.02B 125.46B HKD 3K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 132K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 95K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 63K%	97.4	United States
Roche Holding AG SIX: RO	$323.08B 256.25B CHF 56K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.5B 215.59B GBP 50K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.99B 218.9B CHF 48K%	20.5	Switzerland

chevron_leftBack